BREAKING NEWS: New drug approved by the FDA for Duchenne muscular dystrophy. Learn more about this new treatment option.

Quest Readership Survey: We Want to Hear From You

Share your thoughts today — fill out MDA's Quest 2016 reader survey

After listening to inspiring individuals with neuromuscular diseases and their families, the Muscular Dystrophy Association (MDA) launched a revitalized brand and new look for Quest Magazine in January 2016. We'd like to know what families think of Quest. Please take a few minutes to fill out the Quest Reader Survey and provide your feedback so we can continue to improve the information and resources we share in each issue.

Be sure to let us know what you like about Quest, what we could do better and what you would like to see more (or less) of in its pages. Your responses will remain strictly confidential and will be reported only in total along with the opinions of other respondents.

To thank you for your time, you will be entered into a drawing to receive an Apple Watch, sponsored by Disability Resource Link Inc., or a $100 Visa gift card. Your survey must be received by August 31, 2016, to qualify for entry in the drawing. Thank you in advance for your participation.

MDA Resource Center: We’re Here For You

Our trained specialists are here to provide one-on-one support for every part of your journey. Send a message below or call us at 1-833-ASK-MDA1 (1-833-275-6321). If you live outside the U.S., we may be able to connect you to muscular dystrophy groups in your area, but MDA programs are only available in the U.S.

Request Information